• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Scandinavian Life Science Venture

edit

Scandinavian Life Science Venture is a venture capital firm specializing in start up and growth capital investments in small and mid-sized companies. The firm also considers private equity deals in non-listed companies. It seeks to make investments in the life science sector. The firm typically invests in Nordic region with focus on Sweden and Denmark. It prefers to invest between $1.36 million and $13.66 million in its portfolio companies. The firm prefers to take an equity stake between 15 percent and 35 percent in its portfolio companies with investment horizon of three to five years. It prefers to exit its investments through a trade sale or IPO. Scandinavian Life Science Venture based in Stockholm, Sweden with an additional office in Copenhagen V, Denmark.

Milestones

edit

• 
  Scandinavian Life Science Venture invested in BioPheresis. (5/13/05)
  Posted 7/3/10 at 5:32am via localtechwire.com
• 
  Scandinavian Life Science Venture invested in Light Sciences Oncology. (12/14/05)
  Posted 7/1/10 at 3:25am via lsoncology.com
• 
  Scandinavian Life Science Venture invested in Symphogen. (1/10/06)
  Posted 4/20/10 at 7:35pm via sciencebusiness.net

Investments

Videos

Sources

1. Symphogen gets $25M for clinical trials for bleeding treatment (bulletin.sciencebusiness.net) [edit]
2. LIGHT SCIENCES ONCOLOGY COMPLETES SECOND CLOSING IN $67 MILLION FINANCING FOR LATE STAGE DEVELOPMENT OF LITXâ„¢ AND ANNOUNCES ADDITIONAL DIRECTORS (lsoncology.com) [edit]
3. Cary-Based Biopheresis Raises $8 Million To Back Cancer Treatment System (localtechwire.com) [edit]